LFSC.US F/m Emerald Life Sciences Innovation ETF

ETF Healthcare Equity Emerald Mutual Fund Advisers Trust USA Stocks
- USD
No recent price
Total assets
130M
Expense ratio
-
Dividend yield
-
1-year return
+32.27%
Holdings
38
Since
2024

Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.

What does LFSC.US invest in?

  • Mostly US stocks (97.4%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (100.0%)
  • Top 3 holdings: 24.0% of the fund

Asset allocation

  • US stocks 97.4%
  • Bonds 0.4%
  • Cash 0.1%
  • Other 0.0%

Top holdings

All holdings, sectors and regions

F/m Emerald Life Sciences Innovation ETF performance

Sharpe ratio 0.00
This year
+26.93%
1 year
+32.27%
3 years
-
5 years
-

Volatility 24.7% over 1 year. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

LFSC.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About F/m Emerald Life Sciences Innovation ETF

The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Full fund profile